The power of vascular innovation.

Imagine a readily available, “off the shelf ” bioengineered human acellular vessel (HAV) that could replace a patients own blood vessel or create a new vascular access for patients who require dialysis, without requiring cells or tissue from the patient.

Humacyte is making that happen.

What We Do

Groundbreaking technology

Our unique process, paired with innovation and continued improvement and evolution, puts us at the forefront.